S-1 versus placebo in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE): a randomised, double-blind, multicentre, phase 3 trialMasatoshi Kudo, Takuji Okusaka, Kazushi Numata et al.|The Lancet. Gastroenterology & hepatology|2017Cited by 60